Natural history of end-stage LV dysfunction: has it improved from the classic Franciosa and Cohn Graph?
Jacoby, Daniel
Natural history of end-stage LV dysfunction: has it improved from the classic Franciosa and Cohn Graph? [electronic resource] - Cardiology clinics Nov 2011 - 485-95 p. digital
Publication Type: Journal Article
1558-2264
10.1016/j.ccl.2011.08.012 doi
Adrenergic beta-Antagonists--therapeutic use
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Benzazepines--therapeutic use
Cardiac Resynchronization Therapy
Defibrillators, Implantable
Heart Failure--diagnosis
Heart-Assist Devices
Humans
Hydralazine--therapeutic use
Ivabradine
Mineralocorticoid Receptor Antagonists--therapeutic use
Nitrates--therapeutic use
Renin-Angiotensin System--physiology
Risk Factors
Survival Analysis
Sympathetic Nervous System--physiology
Treatment Outcome
Ventricular Dysfunction, Left--etiology
Ventricular Remodeling--physiology
Natural history of end-stage LV dysfunction: has it improved from the classic Franciosa and Cohn Graph? [electronic resource] - Cardiology clinics Nov 2011 - 485-95 p. digital
Publication Type: Journal Article
1558-2264
10.1016/j.ccl.2011.08.012 doi
Adrenergic beta-Antagonists--therapeutic use
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Benzazepines--therapeutic use
Cardiac Resynchronization Therapy
Defibrillators, Implantable
Heart Failure--diagnosis
Heart-Assist Devices
Humans
Hydralazine--therapeutic use
Ivabradine
Mineralocorticoid Receptor Antagonists--therapeutic use
Nitrates--therapeutic use
Renin-Angiotensin System--physiology
Risk Factors
Survival Analysis
Sympathetic Nervous System--physiology
Treatment Outcome
Ventricular Dysfunction, Left--etiology
Ventricular Remodeling--physiology